Table 1.

Patient characteristics at enrollment (per protocol)

Patient IDAge yGenderHistory of histologically confirmed DFSP (mo)Disease stageLocationLongest tumor diameter (method of assessment)ECOG performance statePrevious therapy of DFSP
ADO-0152F177Local recurrenceTrunk (presternal)3.4 cm (ultrasound)0Surgery
ADO-0250M1PrimaryTrunk (presternal)9.5 cm (ultrasound)0None
ADO-0366M2PrimaryExtremities (upper arm)3.6 cm (MRI)0None
ADO-0474F1PrimaryTrunk (inframammary)5.0 cm (MRI)0None
ADO-0537F1PrimaryExtremities (upper leg)5.9 cm (MRI)0None
ADO-0669F10PrimaryTrunk (upper back)18.3 cm (MRI)1None
ADO-0751F1PrimaryTrunk9.2 cm (ultrasound)0None
ADO-0927F27Local recurrenceTrunk (shoulder/upper back)1.7 cm (ultrasound)0Surgery
ADO-1056F1PrimaryTrunk (lower abdomen)2.7 cm (ultrasound)0None
ADO-1143F1PrimaryTrunk (presternal)4.0 cm (MRI)0None
ADO-1257M294Local recurrenceTrunk (shoulder/upper back)6.0 cm (CT)2Surgery, radiation
ADO-1339F1PrimaryTrunk (presternal)4.5 cm (MRI)0None
ADO-1572F17PrimaryTrunk (upper abdomen)6.8 cm (MRI)2None
ADO-1637F3PrimaryTrunk (lower abdomen)4.0 cm (MRI)0None

NOTE: Characteristics of the per protocol patient population at study enrollment.